AU2978995A - Methods for treating cell proliferative disorders by modulating signal transduction - Google Patents
Methods for treating cell proliferative disorders by modulating signal transductionInfo
- Publication number
- AU2978995A AU2978995A AU29789/95A AU2978995A AU2978995A AU 2978995 A AU2978995 A AU 2978995A AU 29789/95 A AU29789/95 A AU 29789/95A AU 2978995 A AU2978995 A AU 2978995A AU 2978995 A AU2978995 A AU 2978995A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- signal transduction
- cell proliferative
- proliferative disorders
- modulating signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26839094A | 1994-06-30 | 1994-06-30 | |
PCT/EP1995/002532 WO1996000586A2 (en) | 1994-06-30 | 1995-06-29 | Methods for treating cell proliferative disorders by modulating signal transduction |
US268390 | 2002-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2978995A true AU2978995A (en) | 1996-01-25 |
Family
ID=23022786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU29789/95A Abandoned AU2978995A (en) | 1994-06-30 | 1995-06-29 | Methods for treating cell proliferative disorders by modulating signal transduction |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2978995A (en) |
WO (1) | WO1996000586A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6465211B1 (en) | 1998-08-27 | 2002-10-15 | Riken | Nucleic acids, vectors and transformed cells for making and using high affinity IP-3 binding polypeptides |
US7091173B1 (en) * | 2001-10-30 | 2006-08-15 | Myriad Genetics, Inc. | FAP48-interacting proteins and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0520372T3 (en) * | 1991-06-26 | 1997-05-12 | Hoechst Ag | Inositol-phosphate analogues as calcium antagonists |
JPH08502068A (en) * | 1992-09-28 | 1996-03-05 | メレルダウファーマスーティカルズ インコーポレイテッド | Method to antagonize inositol 1,4,5-trisphosphate |
-
1995
- 1995-06-29 WO PCT/EP1995/002532 patent/WO1996000586A2/en active Application Filing
- 1995-06-29 AU AU29789/95A patent/AU2978995A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1996000586A2 (en) | 1996-01-11 |
WO1996000586A3 (en) | 1996-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2595397A (en) | Apparatus for treating neurodegenerative disorders | |
AU3153295A (en) | Methods for treating addictive disorders | |
AU3813397A (en) | Apparatus for treating chondromalicia | |
AU689693B2 (en) | Control apparatus for multi-air-conditioner | |
AU6479596A (en) | Methods for treating diabetes | |
AU5268696A (en) | Novel compounds and methods for therapy | |
AU2326297A (en) | Method for treating liquid materials | |
AU5789396A (en) | Apparatus for skin resurfacing | |
AU4409397A (en) | Method for detecting cell proliferative disorders | |
AU3948897A (en) | Traction apparatus | |
AU2539095A (en) | Depth control apparatus | |
AU1847195A (en) | Apparatus for treating herniated discs | |
AU3161797A (en) | Nerve process growth modulators | |
AU6910994A (en) | Methods and compounds for inhibiting cell proliferative disorders characterized by abnormal (abl) activity | |
AU6714396A (en) | Methods and compositions for treating cell proliferative disorders | |
AU4029195A (en) | Carbon reactivation apparatus | |
AU6508996A (en) | Apparatus for liquid purification | |
AU6866394A (en) | Method for producing liquid fertilizer | |
AUPM456894A0 (en) | Treatment for gastric disorders | |
AU7129796A (en) | Apparatus For The Dosed, Air-Ttransported Distribution Of Substances | |
AU2978995A (en) | Methods for treating cell proliferative disorders by modulating signal transduction | |
AUPM534094A0 (en) | Sharpening apparatus | |
AU5951896A (en) | Novel method for quantitatively measuring apoptosis | |
AU2611695A (en) | Sailboatsystem for controlled gibing | |
AU3387295A (en) | Process and device for regulating and improving water quality |